Los registros los proporcionan patrocinadores e investigadores. Estar en el registro no garantiza seguridad, disponibilidad ni elegibilidad, ni representa un aval. Los títulos, resúmenes y criterios originales del registro se muestran en inglés para conservar su significado.
Listado de WCR consultado: 12 nov 2026.
ReclutandoNCT07928388
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Fase 32 años - No especificadoPalo Alto, California, United States +4 Continued access to MC-1 is required by subjects who have participated in the MEND-PNPO study, as no other pharmaceutical grade P5P is currently commercially available. The protocol duration is planned for until the finished product is commercially a…
ReclutandoNCT07613775
Gingival Recession
No aplica18 años - No especificadoRibeirão Preto, São Paulo, Brazil Gingival recession is a clinical condition in which the gingival margin is displaced apically, exposing the root surface. This condition may be associated with esthetic concerns, dentin hypersensitivity, and difficulties in oral hygiene. Subepithelia…
ReclutandoNCT06479837
Staphylococcal Infections
Observacional2 años - 120 añosBethesda, Maryland, United States Background: Staphylococcus aureus (S.aureus) are bacteria that can make people sick. Sometimes, an S. aureus infection can develop inside the spine; these infections can lead to paralysis and death. Researchers do not know how S. aureus interacts wit…
CompletadoNCT06893926
s100b · Hypoxia-Ischemia, Brain · Fetal Growth Restriction (FGR)
Observacional18 años - No especificadoWarsaw, Poland S100B protein is a biomarker that increases following central nervous system (CNS) damage. Measuring this protein's levels may allow for the early identification of infants at high risk for developmental abnormalities, such as fetal growth restrictio…
Activo, sin reclutamientoNCT05409989
Intracranial Aneurysm
No aplica22 años - 75 añosHollywood, Florida, United States +20 The objective of this study is to generate contemporaneous clinical data to facilitate a reasonable comparison of the performance of the FRED™ X™ device with the performance of the FRED™ device. The data generated from this study will be compared to …
Activo, sin reclutamientoNCT06217185
HER2-positive Breast Cancer · Advanced Breast Cancer
Fase 418 años - 70 añosShijiazhuang, Hebei, China This is a multi-center real-world study, in which patients who meet the inclusion criteria will receive treatment with Pyrotinib + Trastuzumab + Taxanes. Taxanes will be used for 6-8 cycles or discontinued due to intolerable Adverse Events (AEs), aft…
CompletadoNCT04511286
Somatic Symptom Disorder
No aplica18 años - No especificadoStockholm, Sweden This study investigates the feasibility of a general exposure-based treatment protocol that is intended to work for a large variety of patient groups with a clinically significant preoccupation with physical symptoms. This is a prospective single-gro…
ReclutandoNCT07929922
Anterior Cruciate Ligament (ACL) Tear
No aplica15 años - 40 añosColumbus, Ohio, United States +1 The ASPIRATE trial is a randomized controlled trial evaluating the effects of pre- and post-operative knee joint aspiration in patients with an ACL injury. The study aims to determine if removing knee joint fluid can mitigate the increasing inflammat…
CompletadoNCT06710483
Intellectual Disability, Variable
No aplica12 años - 18 añosBoston, Massachusetts, United States This randomized clinical trial is an innovative pilot project to determine the acceptance and impact of telehealth visits on youth with intellectual and developmental disabilities (IDD), their caregivers, and dentists. The impact of the telehealth vi…
CompletadoNCT01207492
Pigmented Villonodular Synovitis · Diffuse-type Giant Cell Tumor · Tenosynovial Giant Cell Tumor
Fase 218 años - No especificadoSanta Monica, California, United States +5 Nilotinib is a drug that is used to treat a form of a blood cancer called leukemia. Nilotinib works by blocking the action of a protein that might be important for the growth of pigmented villonodular synovitis (PVNS). In this research study the inve…
Aún no reclutaNCT07929857
Hair and Scalp Health
No aplica18 años - No especificadoAix-en-Provence, France +1 Cellbooster® Hair (CBH) is a class III medical device, CE marked, HA-based injectable using the patented CHAC Technology. It consists of stabilized Hyaluronic Acid 18mg (6mg/ml) with Amino Acids and Vitamins, and minerals (zinc, copper). The medical …
ReclutandoNCT07886970
Healthy · Health Knowledge, Attitudes, Practice
No aplica18 años - 40 añosBolu, Merkez, Turkey (Türkiye) Interactions with virtual content can enhance the creation and retention of knowledge. While some studies have found that learning methods involving the body-such as tactile manipulation-can lead to deeper understanding and higher achievement scores,…
Consultado en ClinicalTrials.gov: 12 nov 2026. El estado general puede ser distinto al de un centro específico.
